Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Fiorella Vasquez"'
Autor:
Pablo Fernandez-Crehuet, Sofía Haselgruber, Alicia Padial-Gomez, Fiorella Vasquez-Chinchay, Maria Dolores Fernandez-Ballesteros, Irene López-Riquelme, David Jimenez-Gallo, Juan Manuel Segura-Palacios, Marisol Contreras-Steyls, Giovana Fernanda Osorio-Gómez, Juan Carlos Hernández-Rodríguez, Manuel Sanchez-Diaz, Carlos Cuenca-Barrales, Salvador Arias-Santiago, Alejandro Molina-Leyva
Publikováno v:
Dermatology and Therapy, Vol 13, Iss 4, Pp 1029-1038 (2023)
Abstract Introduction Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease. Biologic drugs have a key role in the long-term anti-inflammatory treatment of moderate to severe patients due to their immunomodulatory properties. The aim o
Externí odkaz:
https://doaj.org/article/de1c5eaca736467a882330bcd75ad47a
Autor:
Fiorella Vasquez Chinchay, Manuel Galán-Gutiérrez, Jose C. Armario-Hita, Amalia Pérez-Gil, Ricardo Ruiz-Villaverde, Lourdes Rodriguez-Fernandez-Freire
Publikováno v:
F1000Research, Vol 11 (2022)
Background: Psoriasis is a chronic inflammatory disease which can impact quality of life. In the past decade multiple biologic treatments have been released with encouraging results. Guselkumab is a monoclonal antibody targeting IL-23p19. Multiple ra
Externí odkaz:
https://doaj.org/article/407b086b973448d79f9c3720c708bd7d
Autor:
Ricardo Ruiz-Villaverde, Fiorella Vasquez-Chinchay, Lourdes Rodriguez-Fernandez-Freire, Jose C. Armario-Hita, Amalia Pérez-Gil, Manuel Galán-Gutiérrez
Publikováno v:
Life, Vol 12, Iss 9, p 1412 (2022)
A fast skin clearance is the main goal to achieve in psoriasis treatment. Patients that present a fast and exceptional improvement with treatment are called super-responders (SR). There is no consensus on the definition of SR with respect to psoriasi
Externí odkaz:
https://doaj.org/article/168265c2256b44b0aeaabfef636ce2a0
Publikováno v:
Revista Arbitrada Interdisciplinaria Koinonía, Vol 4, Iss 8, Pp 262-287 (2019)
The high level of competitiveness in the current market has forced companies to give a faster response to customer needs. Therefore logistics has positioned itself as a set of processes that allow delivering value products to the customer in the amou
Externí odkaz:
https://doaj.org/article/867e15515b6d4294bb99a31c8d0126c4
Autor:
Ruiz‐Villaverde, Ricardo1 (AUTHOR) ricardo.ruiz.villaverde.sspa@juntadeandalucia.es, Chinchay, Fiorella Vasquez2 (AUTHOR), Rodriguez‐Fernandez‐Freire, Lourdes3 (AUTHOR), Armario‐Hita, Jose C.4 (AUTHOR), Pérez‐Gil, Amalia5 (AUTHOR), Galán‐Gutiérrez, Manuel6 (AUTHOR)
Publikováno v:
Dermatologic Therapy. Nov2022, Vol. 35 Issue 11, p1-5. 5p.
Autor:
Ricardo Ruiz‐Villaverde, Fiorella Vasquez Chinchay, Lourdes Rodriguez‐Fernandez‐Freire, Jose C. Armario‐Hita, Amalia Pérez‐Gil, Manuel Galán‐Gutiérrez
Publikováno v:
Dermatologic Therapy. 35
Psoriasis (PSO) is an inflammatory disease that emerges as a dysregulation of the interleukin 23 (IL23)/Th17 axis. There are many biologic alternatives to treat PSO that are administered monthly, every 2 months and every 3 months. Guselkumab (GUS) is
Autor:
Ricardo Ruiz‐Villaverde, Lourdes Rodriguez‐Fernandez‐Freire, Jose Carlos Armario‐Hita, Amalia Pérez‐Gil, Fiorella Vasquez Chinchay, Manuel Galán‐Gutiérrez
The IL23/Th17 axis plays a strategic role in psoriasis (PSO). Guselkumab (GUS) is a selective inhibitor of the IL23p19 subunit. Its introduction has managed to increase the levels of efficacy, safety and survival in PSO. In real clinical practice, pa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bf76cbc68be58ff598376215c2505b23
https://hdl.handle.net/10668/19939
https://hdl.handle.net/10668/19939
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Ricardo Ruiz-Villaverde, Lourdes Rodriguez-Fernandez-Freire, Jose C. Armario-Hita, Amalia Pérez-Gil, Fiorella Vasquez Chinchay, Manuel Galán-Gutiérrez
Publikováno v:
F1000Research. 11:1178
Background: Psoriasis is a chronic inflammatory disease which can impact quality of life. In the past decade multiple biologic treatments have been released with encouraging results. Guselkumab is a monoclonal antibody targeting IL-23p19. Multiple ra
Autor:
L. Rodriguez-Fernandez-Freire, Ricardo Ruiz-Villaverde, Jose C. Armario-Hita, Fiorella Vasquez, Amalia Perez-Gil, Leandro Martinez-Pilar, Manuel Galan-Gutierrez
Publikováno v:
Journal of the American Academy of Dermatology. 87:AB164